Literature DB >> 20117292

Suberoylanilide hydroxyamic acid modification of chromatin architecture affects DNA break formation and repair.

Sheetal Singh1, Hongan Le, Shyh-Jen Shih, Bay Ho, Andrew T Vaughan.   

Abstract

PURPOSE: Chromatin-modifying compounds that inhibit the activity of histone deacetylases have shown potency as radiosensitizers, but the action of these drugs at a molecular level is not clear. Here we investigated the effect of suberoylanilide hydroxyamic acid (SAHA) on DNA breaks and their repair and induction of rearrangements. METHODS AND MATERIALS: The effect of SAHA on both clonogenic survival and repair was assessed using cell lines SCC-25, MCF7, and TK6. In order to study unique DNA double-strand breaks, anti-CD95 antibody was employed to introduce a DNA double-strand break at a known location within the 11q23 region. The effects of SAHA on DNA cleavage and rearrangements were analyzed by ligation-mediated PCR and inverse PCR, respectively.
RESULTS: SAHA acts as radiosensitizer at 1 microM, with dose enhancement factors (DEFs) at 10% survival of: SCC-25 - 1.24 +/- 0.05; MCF7 - 1.16 +/- 0.09 and TK6 - 1.17 +/- 0.05, and it reduced the capacity of SCC-25 cells to repair radiation induced lesions. Additionally, SAHA treatment diffused site-specific fragmentation over at least 1 kbp in TK6 cells. Chromosomal rearrangements produced in TK6 cells exposed to SAHA showed a reduction in microhomology at the breakpoint between 11q23 and partner chromosomes.
CONCLUSIONS: SAHA shows efficacy as a radiosensitizer at clinically obtainable levels. In its presence, targeted DNA strand breaks occur over an expanded region, indicating increased chromatin access. The rejoining of such breaks is degraded by SAHA when measured as rearrangements at the molecular level and rejoining that contributes to cell survival. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20117292      PMCID: PMC2818091          DOI: 10.1016/j.ijrobp.2009.08.031

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  35 in total

1.  Insights into the sites of X ray and neutron induced chromosomal aberrations in human lymphocytes using COBRA-MFISH.

Authors:  F Darroudi; V Bezrookove; J Fomina; W E Mesker; J C A G Wiegant; A K Raap; H J Tanke
Journal:  Radiat Prot Dosimetry       Date:  2002       Impact factor: 0.972

2.  Etoposide-treatment and MLL rearrangements.

Authors:  Rolf Marschalek
Journal:  Eur J Haematol       Date:  2008-12       Impact factor: 2.997

3.  SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway.

Authors:  A Hrzenjak; M-L Kremser; B Strohmeier; F Moinfar; K Zatloukal; H Denk
Journal:  J Pathol       Date:  2008-12       Impact factor: 7.996

4.  A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study.

Authors:  Thehang H Luu; Robert J Morgan; Lucille Leong; Dean Lim; Mark McNamara; Jana Portnow; Paul Frankel; David D Smith; James H Doroshow; Carol Wong; Ana Aparicio; David R Gandara; George Somlo
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

Review 5.  Development of vorinostat: current applications and future perspectives for cancer therapy.

Authors:  Victoria M Richon; Jose Garcia-Vargas; James S Hardwick
Journal:  Cancer Lett       Date:  2009-01-31       Impact factor: 8.679

6.  Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma.

Authors:  M Crump; B Coiffier; E D Jacobsen; L Sun; J L Ricker; H Xie; S R Frankel; S S Randolph; B D Cheson
Journal:  Ann Oncol       Date:  2008-02-21       Impact factor: 32.976

Review 7.  Enhancing the apoptotic and therapeutic effects of HDAC inhibitors.

Authors:  Ailsa J Frew; Ricky W Johnstone; Jessica E Bolden
Journal:  Cancer Lett       Date:  2009-04-08       Impact factor: 8.679

8.  Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding.

Authors:  Hongan Le; Sheetal Singh; Shyh-Jen Shih; Nga Du; Sabine Schnyder; Grace A Loredo; Christine Bien; Laura Michaelis; Amir Toor; Manuel O Diaz; Andrew T Vaughan
Journal:  Genes Chromosomes Cancer       Date:  2009-09       Impact factor: 5.006

9.  Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias.

Authors:  Ken Shiozawa; Takeo Nakanishi; Ming Tan; Hong-Bin Fang; Wen-chyi Wang; Martin J Edelman; David Carlton; Ivana Gojo; Edward A Sausville; Douglas D Ross
Journal:  Clin Cancer Res       Date:  2009-02-17       Impact factor: 12.531

10.  Impaired NHEJ function in multiple myeloma.

Authors:  Clara Yang; Christopher Betti; Sheetal Singh; Amir Toor; Andrew Vaughan
Journal:  Mutat Res       Date:  2008-11-05       Impact factor: 2.433

View more
  3 in total

1.  Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy.

Authors:  Samantha Y A Terry; Katherine A Vallis
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-02-14       Impact factor: 7.038

2.  Histone deacetylase regulation of ATM-mediated DNA damage signaling.

Authors:  K Ted Thurn; Scott Thomas; Paromita Raha; Ian Qureshi; Pamela N Munster
Journal:  Mol Cancer Ther       Date:  2013-08-12       Impact factor: 6.261

3.  Predicting chemotherapeutic drug combinations through gene network profiling.

Authors:  Thi Thuy Trang Nguyen; Jacqueline Kia Kee Chua; Kwi Shan Seah; Seok Hwee Koo; Jie Yin Yee; Eugene Guorong Yang; Kim Kiat Lim; Shermaine Yu Wen Pang; Audrey Yuen; Louxin Zhang; Wee Han Ang; Brian Dymock; Edmund Jon Deoon Lee; Ee Sin Chen
Journal:  Sci Rep       Date:  2016-01-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.